nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARG—pancreatic cancer	0.464	1	CbGaD
Bezafibrate—CYP1A1—Dacarbazine—pancreatic cancer	0.0668	0.19	CbGbCtD
Bezafibrate—SLCO1B1—Irinotecan—pancreatic cancer	0.0557	0.158	CbGbCtD
Bezafibrate—CYP1A1—Tamoxifen—pancreatic cancer	0.0531	0.151	CbGbCtD
Bezafibrate—CYP1A1—Erlotinib—pancreatic cancer	0.0452	0.128	CbGbCtD
Bezafibrate—CYP2C8—Tamoxifen—pancreatic cancer	0.0307	0.0872	CbGbCtD
Bezafibrate—CYP2C8—Erlotinib—pancreatic cancer	0.0261	0.0741	CbGbCtD
Bezafibrate—CYP2C8—Fluorouracil—pancreatic cancer	0.0226	0.0642	CbGbCtD
Bezafibrate—CYP3A4—Tamoxifen—pancreatic cancer	0.0124	0.0353	CbGbCtD
Bezafibrate—CYP3A4—Erlotinib—pancreatic cancer	0.0106	0.0301	CbGbCtD
Bezafibrate—CYP3A4—Irinotecan—pancreatic cancer	0.00955	0.0271	CbGbCtD
Bezafibrate—CYP3A4—Docetaxel—pancreatic cancer	0.007	0.0199	CbGbCtD
Bezafibrate—CYP3A4—Sunitinib—pancreatic cancer	0.00697	0.0198	CbGbCtD
Bezafibrate—CYP3A4—Doxorubicin—pancreatic cancer	0.00522	0.0148	CbGbCtD
Bezafibrate—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00308	1	CbGdCrCtD
Bezafibrate—PPARD—islet of Langerhans—pancreatic cancer	0.00192	0.137	CbGeAlD
Bezafibrate—HMGCR—gall bladder—pancreatic cancer	0.00166	0.119	CbGeAlD
Bezafibrate—PPARD—pancreas—pancreatic cancer	0.00135	0.0965	CbGeAlD
Bezafibrate—PPARD—digestive system—pancreatic cancer	0.00115	0.0824	CbGeAlD
Bezafibrate—PPARA—pancreas—pancreatic cancer	0.00115	0.0822	CbGeAlD
Bezafibrate—Balsalazide—PPARG—pancreatic cancer	0.0011	0.372	CrCbGaD
Bezafibrate—HMGCR—islet of Langerhans—pancreatic cancer	0.00109	0.0778	CbGeAlD
Bezafibrate—PPARA—digestive system—pancreatic cancer	0.00098	0.0702	CbGeAlD
Bezafibrate—PPARG—islet of Langerhans—pancreatic cancer	0.000897	0.0643	CbGeAlD
Bezafibrate—HMGCR—pancreas—pancreatic cancer	0.000764	0.0547	CbGeAlD
Bezafibrate—Indomethacin—CXCL8—pancreatic cancer	0.000704	0.237	CrCbGaD
Bezafibrate—HMGCR—digestive system—pancreatic cancer	0.000652	0.0467	CbGeAlD
Bezafibrate—PPARG—pancreas—pancreatic cancer	0.000631	0.0452	CbGeAlD
Bezafibrate—SLCO1B1—digestive system—pancreatic cancer	0.000625	0.0448	CbGeAlD
Bezafibrate—PPARG—digestive system—pancreatic cancer	0.000539	0.0386	CbGeAlD
Bezafibrate—Indomethacin—PPARG—pancreatic cancer	0.000486	0.164	CrCbGaD
Bezafibrate—Balsalazide—PTGS2—pancreatic cancer	0.000466	0.157	CrCbGaD
Bezafibrate—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.000387	0.00371	CcSEcCtD
Bezafibrate—Myalgia—Tamoxifen—pancreatic cancer	0.000387	0.00371	CcSEcCtD
Bezafibrate—Myocardial infarction—Fluorouracil—pancreatic cancer	0.000385	0.00369	CcSEcCtD
Bezafibrate—Flatulence—Sunitinib—pancreatic cancer	0.000384	0.00367	CcSEcCtD
Bezafibrate—Myalgia—Erlotinib—pancreatic cancer	0.000383	0.00367	CcSEcCtD
Bezafibrate—Muscle spasms—Sunitinib—pancreatic cancer	0.000374	0.00358	CcSEcCtD
Bezafibrate—Infection—Tamoxifen—pancreatic cancer	0.000368	0.00353	CcSEcCtD
Bezafibrate—Infection—Erlotinib—pancreatic cancer	0.000365	0.00349	CcSEcCtD
Bezafibrate—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000363	0.00348	CcSEcCtD
Bezafibrate—Migraine—Docetaxel—pancreatic cancer	0.000362	0.00347	CcSEcCtD
Bezafibrate—Anaemia—Sunitinib—pancreatic cancer	0.00036	0.00345	CcSEcCtD
Bezafibrate—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000359	0.00344	CcSEcCtD
Bezafibrate—Pharyngitis—Gemcitabine—pancreatic cancer	0.000356	0.00341	CcSEcCtD
Bezafibrate—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000354	0.00339	CcSEcCtD
Bezafibrate—Urethral disorder—Gemcitabine—pancreatic cancer	0.000352	0.00337	CcSEcCtD
Bezafibrate—Pharyngitis—Fluorouracil—pancreatic cancer	0.00035	0.00335	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—pancreatic cancer	0.000342	0.00328	CcSEcCtD
Bezafibrate—Liver function test abnormal—Docetaxel—pancreatic cancer	0.00034	0.00326	CcSEcCtD
Bezafibrate—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000339	0.00325	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000338	0.00324	CcSEcCtD
Bezafibrate—Insomnia—Tamoxifen—pancreatic cancer	0.000335	0.00321	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000334	0.0032	CcSEcCtD
Bezafibrate—Insomnia—Erlotinib—pancreatic cancer	0.000332	0.00318	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000331	0.00317	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000331	0.00317	CcSEcCtD
Bezafibrate—Cramp muscle—Docetaxel—pancreatic cancer	0.000331	0.00317	CcSEcCtD
Bezafibrate—Myalgia—Sunitinib—pancreatic cancer	0.000331	0.00317	CcSEcCtD
Bezafibrate—CYP1A1—digestive system—pancreatic cancer	0.000328	0.0235	CbGeAlD
Bezafibrate—Dyspepsia—Tamoxifen—pancreatic cancer	0.000326	0.00313	CcSEcCtD
Bezafibrate—Alopecia—Irinotecan—pancreatic cancer	0.000325	0.00312	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000325	0.00311	CcSEcCtD
Bezafibrate—Dyspepsia—Erlotinib—pancreatic cancer	0.000323	0.00309	CcSEcCtD
Bezafibrate—Pain—Tamoxifen—pancreatic cancer	0.000317	0.00304	CcSEcCtD
Bezafibrate—Constipation—Tamoxifen—pancreatic cancer	0.000317	0.00304	CcSEcCtD
Bezafibrate—Alopecia—Gemcitabine—pancreatic cancer	0.000317	0.00304	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—pancreatic cancer	0.000316	0.00303	CcSEcCtD
Bezafibrate—Flatulence—Irinotecan—pancreatic cancer	0.000316	0.00303	CcSEcCtD
Bezafibrate—Infection—Sunitinib—pancreatic cancer	0.000316	0.00302	CcSEcCtD
Bezafibrate—Constipation—Erlotinib—pancreatic cancer	0.000314	0.00301	CcSEcCtD
Bezafibrate—Pain—Erlotinib—pancreatic cancer	0.000314	0.00301	CcSEcCtD
Bezafibrate—Erythema—Gemcitabine—pancreatic cancer	0.000312	0.00299	CcSEcCtD
Bezafibrate—Alopecia—Fluorouracil—pancreatic cancer	0.000312	0.00299	CcSEcCtD
Bezafibrate—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000311	0.00298	CcSEcCtD
Bezafibrate—Muscle spasms—Irinotecan—pancreatic cancer	0.000308	0.00295	CcSEcCtD
Bezafibrate—Erythema—Fluorouracil—pancreatic cancer	0.000307	0.00294	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000303	0.00291	CcSEcCtD
Bezafibrate—Pancytopenia—Docetaxel—pancreatic cancer	0.000302	0.00289	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.0003	0.00287	CcSEcCtD
Bezafibrate—Anaemia—Irinotecan—pancreatic cancer	0.000296	0.00284	CcSEcCtD
Bezafibrate—Urticaria—Tamoxifen—pancreatic cancer	0.000295	0.00282	CcSEcCtD
Bezafibrate—Abdominal pain—Tamoxifen—pancreatic cancer	0.000293	0.00281	CcSEcCtD
Bezafibrate—Abdominal pain—Erlotinib—pancreatic cancer	0.00029	0.00278	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000289	0.00277	CcSEcCtD
Bezafibrate—Anaemia—Gemcitabine—pancreatic cancer	0.000289	0.00277	CcSEcCtD
Bezafibrate—Insomnia—Sunitinib—pancreatic cancer	0.000287	0.00275	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.000285	0.00273	CcSEcCtD
Bezafibrate—Anaemia—Fluorouracil—pancreatic cancer	0.000284	0.00272	CcSEcCtD
Bezafibrate—Photosensitivity—Epirubicin—pancreatic cancer	0.000283	0.00271	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000281	0.00269	CcSEcCtD
Bezafibrate—Dyspepsia—Sunitinib—pancreatic cancer	0.00028	0.00268	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00028	0.00268	CcSEcCtD
Bezafibrate—Myocardial infarction—Docetaxel—pancreatic cancer	0.000278	0.00266	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—pancreatic cancer	0.000277	0.00266	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—pancreatic cancer	0.000276	0.00265	CcSEcCtD
Bezafibrate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000273	0.00262	CcSEcCtD
Bezafibrate—Pain—Sunitinib—pancreatic cancer	0.000272	0.0026	CcSEcCtD
Bezafibrate—Constipation—Sunitinib—pancreatic cancer	0.000272	0.0026	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—pancreatic cancer	0.000269	0.00258	CcSEcCtD
Bezafibrate—Myalgia—Gemcitabine—pancreatic cancer	0.000266	0.00255	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000264	0.00253	CcSEcCtD
Bezafibrate—Pruritus—Tamoxifen—pancreatic cancer	0.000262	0.00251	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—pancreatic cancer	0.000262	0.00251	CcSEcCtD
Bezafibrate—Myalgia—Fluorouracil—pancreatic cancer	0.000261	0.0025	CcSEcCtD
Bezafibrate—Infection—Irinotecan—pancreatic cancer	0.00026	0.00249	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00026	0.00249	CcSEcCtD
Bezafibrate—Pruritus—Erlotinib—pancreatic cancer	0.00026	0.00249	CcSEcCtD
Bezafibrate—Purpura—Epirubicin—pancreatic cancer	0.000258	0.00247	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—pancreatic cancer	0.000257	0.00246	CcSEcCtD
Bezafibrate—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000256	0.00245	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—pancreatic cancer	0.000256	0.00245	CcSEcCtD
Bezafibrate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000254	0.00243	CcSEcCtD
Bezafibrate—Infection—Gemcitabine—pancreatic cancer	0.000253	0.00243	CcSEcCtD
Bezafibrate—Pharyngitis—Docetaxel—pancreatic cancer	0.000253	0.00242	CcSEcCtD
Bezafibrate—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000251	0.00241	CcSEcCtD
Bezafibrate—Abdominal pain—Sunitinib—pancreatic cancer	0.000251	0.00241	CcSEcCtD
Bezafibrate—Diarrhoea—Erlotinib—pancreatic cancer	0.000251	0.00241	CcSEcCtD
Bezafibrate—Urethral disorder—Docetaxel—pancreatic cancer	0.00025	0.00239	CcSEcCtD
Bezafibrate—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00025	0.00239	CcSEcCtD
Bezafibrate—Infection—Fluorouracil—pancreatic cancer	0.000249	0.00239	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—pancreatic cancer	0.000249	0.00238	CcSEcCtD
Bezafibrate—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000245	0.00235	CcSEcCtD
Bezafibrate—Dizziness—Tamoxifen—pancreatic cancer	0.000245	0.00235	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—pancreatic cancer	0.000244	0.00234	CcSEcCtD
Bezafibrate—Dizziness—Erlotinib—pancreatic cancer	0.000243	0.00232	CcSEcCtD
Bezafibrate—Erythema multiforme—Docetaxel—pancreatic cancer	0.000241	0.00231	CcSEcCtD
Bezafibrate—CYP3A4—digestive system—pancreatic cancer	0.000241	0.0172	CbGeAlD
Bezafibrate—Purpura—Doxorubicin—pancreatic cancer	0.000238	0.00228	CcSEcCtD
Bezafibrate—Insomnia—Irinotecan—pancreatic cancer	0.000237	0.00227	CcSEcCtD
Bezafibrate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000234	0.00224	CcSEcCtD
Bezafibrate—Rash—Tamoxifen—pancreatic cancer	0.000234	0.00224	CcSEcCtD
Bezafibrate—Dermatitis—Tamoxifen—pancreatic cancer	0.000234	0.00224	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000233	0.00223	CcSEcCtD
Bezafibrate—Headache—Tamoxifen—pancreatic cancer	0.000232	0.00223	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000232	0.00222	CcSEcCtD
Bezafibrate—Rash—Erlotinib—pancreatic cancer	0.000231	0.00222	CcSEcCtD
Bezafibrate—Dermatitis—Erlotinib—pancreatic cancer	0.000231	0.00221	CcSEcCtD
Bezafibrate—Insomnia—Gemcitabine—pancreatic cancer	0.000231	0.00221	CcSEcCtD
Bezafibrate—Dyspepsia—Irinotecan—pancreatic cancer	0.00023	0.00221	CcSEcCtD
Bezafibrate—Headache—Erlotinib—pancreatic cancer	0.00023	0.0022	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000229	0.0022	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000228	0.00219	CcSEcCtD
Bezafibrate—Insomnia—Fluorouracil—pancreatic cancer	0.000227	0.00217	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—pancreatic cancer	0.000226	0.00217	CcSEcCtD
Bezafibrate—Alopecia—Docetaxel—pancreatic cancer	0.000225	0.00216	CcSEcCtD
Bezafibrate—Pruritus—Sunitinib—pancreatic cancer	0.000225	0.00215	CcSEcCtD
Bezafibrate—Pain—Irinotecan—pancreatic cancer	0.000224	0.00214	CcSEcCtD
Bezafibrate—Constipation—Irinotecan—pancreatic cancer	0.000224	0.00214	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000224	0.00214	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000224	0.00214	CcSEcCtD
Bezafibrate—Erythema—Docetaxel—pancreatic cancer	0.000222	0.00212	CcSEcCtD
Bezafibrate—Dyspepsia—Fluorouracil—pancreatic cancer	0.000221	0.00211	CcSEcCtD
Bezafibrate—Nausea—Tamoxifen—pancreatic cancer	0.00022	0.00211	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—pancreatic cancer	0.00022	0.0021	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—pancreatic cancer	0.000219	0.0021	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000219	0.0021	CcSEcCtD
Bezafibrate—Pain—Gemcitabine—pancreatic cancer	0.000218	0.00209	CcSEcCtD
Bezafibrate—Constipation—Gemcitabine—pancreatic cancer	0.000218	0.00209	CcSEcCtD
Bezafibrate—Nausea—Erlotinib—pancreatic cancer	0.000218	0.00209	CcSEcCtD
Bezafibrate—Diarrhoea—Sunitinib—pancreatic cancer	0.000217	0.00208	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000215	0.00206	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—pancreatic cancer	0.000215	0.00206	CcSEcCtD
Bezafibrate—Pain—Fluorouracil—pancreatic cancer	0.000214	0.00205	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000214	0.00205	CcSEcCtD
Bezafibrate—Muscle spasms—Docetaxel—pancreatic cancer	0.000213	0.00204	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000212	0.00203	CcSEcCtD
Bezafibrate—Dizziness—Sunitinib—pancreatic cancer	0.00021	0.00201	CcSEcCtD
Bezafibrate—Abdominal pain—Irinotecan—pancreatic cancer	0.000207	0.00198	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000207	0.00198	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000207	0.00198	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—pancreatic cancer	0.000206	0.00198	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—pancreatic cancer	0.000205	0.0693	CrCbGaD
Bezafibrate—Anaemia—Docetaxel—pancreatic cancer	0.000205	0.00196	CcSEcCtD
Bezafibrate—Pancytopenia—Epirubicin—pancreatic cancer	0.000204	0.00195	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—pancreatic cancer	0.000203	0.00195	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000203	0.00194	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—pancreatic cancer	0.000203	0.00194	CcSEcCtD
Bezafibrate—Rash—Sunitinib—pancreatic cancer	0.0002	0.00192	CcSEcCtD
Bezafibrate—Dermatitis—Sunitinib—pancreatic cancer	0.0002	0.00192	CcSEcCtD
Bezafibrate—Urticaria—Fluorouracil—pancreatic cancer	0.000199	0.00191	CcSEcCtD
Bezafibrate—Headache—Sunitinib—pancreatic cancer	0.000199	0.00191	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—pancreatic cancer	0.000198	0.0019	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000196	0.00188	CcSEcCtD
Bezafibrate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000193	0.00185	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—pancreatic cancer	0.000191	0.00183	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00019	0.00182	CcSEcCtD
Bezafibrate—Myalgia—Docetaxel—pancreatic cancer	0.000189	0.00181	CcSEcCtD
Bezafibrate—Nausea—Sunitinib—pancreatic cancer	0.000189	0.00181	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—pancreatic cancer	0.000189	0.00181	CcSEcCtD
Bezafibrate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000185	0.00177	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000181	0.00174	CcSEcCtD
Bezafibrate—Pruritus—Gemcitabine—pancreatic cancer	0.00018	0.00173	CcSEcCtD
Bezafibrate—Infection—Docetaxel—pancreatic cancer	0.00018	0.00172	CcSEcCtD
Bezafibrate—Diarrhoea—Irinotecan—pancreatic cancer	0.000179	0.00172	CcSEcCtD
Bezafibrate—Pruritus—Fluorouracil—pancreatic cancer	0.000177	0.0017	CcSEcCtD
Bezafibrate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000177	0.0017	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000175	0.00168	CcSEcCtD
Bezafibrate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000174	0.00167	CcSEcCtD
Bezafibrate—Dizziness—Irinotecan—pancreatic cancer	0.000173	0.00166	CcSEcCtD
Bezafibrate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000171	0.00164	CcSEcCtD
Bezafibrate—Pharyngitis—Epirubicin—pancreatic cancer	0.00017	0.00163	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00017	0.00162	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—pancreatic cancer	0.000168	0.00161	CcSEcCtD
Bezafibrate—Dizziness—Fluorouracil—pancreatic cancer	0.000166	0.00159	CcSEcCtD
Bezafibrate—Rash—Irinotecan—pancreatic cancer	0.000165	0.00158	CcSEcCtD
Bezafibrate—Dermatitis—Irinotecan—pancreatic cancer	0.000165	0.00158	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000165	0.00158	CcSEcCtD
Bezafibrate—Headache—Irinotecan—pancreatic cancer	0.000164	0.00157	CcSEcCtD
Bezafibrate—Insomnia—Docetaxel—pancreatic cancer	0.000164	0.00157	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—pancreatic cancer	0.000162	0.00156	CcSEcCtD
Bezafibrate—Rash—Gemcitabine—pancreatic cancer	0.000161	0.00154	CcSEcCtD
Bezafibrate—Dermatitis—Gemcitabine—pancreatic cancer	0.000161	0.00154	CcSEcCtD
Bezafibrate—Headache—Gemcitabine—pancreatic cancer	0.00016	0.00153	CcSEcCtD
Bezafibrate—Dyspepsia—Docetaxel—pancreatic cancer	0.000159	0.00153	CcSEcCtD
Bezafibrate—Rash—Fluorouracil—pancreatic cancer	0.000158	0.00151	CcSEcCtD
Bezafibrate—Dermatitis—Fluorouracil—pancreatic cancer	0.000158	0.00151	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000158	0.00151	CcSEcCtD
Bezafibrate—Headache—Fluorouracil—pancreatic cancer	0.000157	0.0015	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000157	0.0015	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000156	0.00149	CcSEcCtD
Bezafibrate—Nausea—Irinotecan—pancreatic cancer	0.000155	0.00149	CcSEcCtD
Bezafibrate—Pain—Docetaxel—pancreatic cancer	0.000155	0.00148	CcSEcCtD
Bezafibrate—Constipation—Docetaxel—pancreatic cancer	0.000155	0.00148	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—pancreatic cancer	0.000152	0.00145	CcSEcCtD
Bezafibrate—Nausea—Gemcitabine—pancreatic cancer	0.000151	0.00145	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00015	0.00144	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—pancreatic cancer	0.000149	0.00143	CcSEcCtD
Bezafibrate—Nausea—Fluorouracil—pancreatic cancer	0.000149	0.00143	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000148	0.00142	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—pancreatic cancer	0.000147	0.00141	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—pancreatic cancer	0.000144	0.00138	CcSEcCtD
Bezafibrate—Abdominal pain—Docetaxel—pancreatic cancer	0.000143	0.00137	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—pancreatic cancer	0.00014	0.00135	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—pancreatic cancer	0.000138	0.00133	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—pancreatic cancer	0.000138	0.00132	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—pancreatic cancer	0.000136	0.00131	CcSEcCtD
Bezafibrate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000133	0.00128	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000133	0.00127	CcSEcCtD
Bezafibrate—Pruritus—Docetaxel—pancreatic cancer	0.000128	0.00123	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—pancreatic cancer	0.000128	0.00122	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—pancreatic cancer	0.000127	0.00122	CcSEcCtD
Bezafibrate—Diarrhoea—Docetaxel—pancreatic cancer	0.000124	0.00119	CcSEcCtD
Bezafibrate—Infection—Epirubicin—pancreatic cancer	0.000121	0.00116	CcSEcCtD
Bezafibrate—Dizziness—Docetaxel—pancreatic cancer	0.00012	0.00115	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000119	0.00114	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—pancreatic cancer	0.000118	0.00113	CcSEcCtD
Bezafibrate—Rash—Docetaxel—pancreatic cancer	0.000114	0.00109	CcSEcCtD
Bezafibrate—Dermatitis—Docetaxel—pancreatic cancer	0.000114	0.00109	CcSEcCtD
Bezafibrate—Headache—Docetaxel—pancreatic cancer	0.000113	0.00109	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—pancreatic cancer	0.000112	0.00107	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000111	0.00106	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000111	0.00106	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—pancreatic cancer	0.00011	0.00106	CcSEcCtD
Bezafibrate—Nausea—Docetaxel—pancreatic cancer	0.000107	0.00103	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—pancreatic cancer	0.000107	0.00103	CcSEcCtD
Bezafibrate—Pain—Epirubicin—pancreatic cancer	0.000104	0.000999	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—pancreatic cancer	0.000104	0.000999	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000103	0.000985	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—pancreatic cancer	0.000102	0.000978	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.98e-05	0.000956	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—pancreatic cancer	9.94e-05	0.000952	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—pancreatic cancer	9.69e-05	0.000929	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—pancreatic cancer	9.65e-05	0.000925	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—pancreatic cancer	9.65e-05	0.000925	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—pancreatic cancer	9.64e-05	0.000924	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.23e-05	0.000884	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—pancreatic cancer	8.99e-05	0.000861	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—pancreatic cancer	8.97e-05	0.000859	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—pancreatic cancer	8.92e-05	0.000855	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—pancreatic cancer	8.63e-05	0.000827	CcSEcCtD
Bezafibrate—Diarrhoea—Epirubicin—pancreatic cancer	8.35e-05	0.0008	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—pancreatic cancer	8.32e-05	0.000797	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—pancreatic cancer	8.07e-05	0.000773	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—pancreatic cancer	7.99e-05	0.000765	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—pancreatic cancer	7.72e-05	0.00074	CcSEcCtD
Bezafibrate—Rash—Epirubicin—pancreatic cancer	7.69e-05	0.000737	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—pancreatic cancer	7.68e-05	0.000736	CcSEcCtD
Bezafibrate—Headache—Epirubicin—pancreatic cancer	7.64e-05	0.000732	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—pancreatic cancer	7.46e-05	0.000715	CcSEcCtD
Bezafibrate—Nausea—Epirubicin—pancreatic cancer	7.25e-05	0.000694	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—pancreatic cancer	7.12e-05	0.000682	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—pancreatic cancer	7.11e-05	0.000681	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—pancreatic cancer	7.07e-05	0.000677	CcSEcCtD
Bezafibrate—Nausea—Doxorubicin—pancreatic cancer	6.7e-05	0.000642	CcSEcCtD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	4.86e-05	0.000816	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—SMAD4—pancreatic cancer	4.73e-05	0.000794	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.71e-05	0.00079	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SLC2A2—pancreatic cancer	4.7e-05	0.000788	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ARG2—pancreatic cancer	4.68e-05	0.000785	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.65e-05	0.00078	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—PTEN—pancreatic cancer	4.64e-05	0.000778	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HES1—pancreatic cancer	4.62e-05	0.000775	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GLP1R—pancreatic cancer	4.6e-05	0.000772	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—PPARG—pancreatic cancer	4.59e-05	0.000771	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—EZH2—pancreatic cancer	4.58e-05	0.000769	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—DPYD—pancreatic cancer	4.53e-05	0.00076	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.48e-05	0.000753	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH3—pancreatic cancer	4.48e-05	0.000752	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SMAD4—pancreatic cancer	4.43e-05	0.000744	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—pancreatic cancer	4.42e-05	0.000741	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CD44—pancreatic cancer	4.37e-05	0.000733	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC2A2—pancreatic cancer	4.29e-05	0.000721	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.27e-05	0.000717	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.25e-05	0.000713	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	4.25e-05	0.000713	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—HSPA1A—pancreatic cancer	4.25e-05	0.000713	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.24e-05	0.000711	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP2—pancreatic cancer	4.22e-05	0.000708	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GCG—pancreatic cancer	4.18e-05	0.000702	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.1e-05	0.000688	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TYMP—pancreatic cancer	4.09e-05	0.000686	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.08e-05	0.000686	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MEN1—pancreatic cancer	3.99e-05	0.000669	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—STK11—pancreatic cancer	3.93e-05	0.00066	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH4—pancreatic cancer	3.78e-05	0.000634	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.74e-05	0.000627	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	3.71e-05	0.000622	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KDR—pancreatic cancer	3.7e-05	0.000621	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.69e-05	0.00062	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ARG2—pancreatic cancer	3.68e-05	0.000618	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—pancreatic cancer	3.65e-05	0.000613	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	3.64e-05	0.000611	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CD44—pancreatic cancer	3.64e-05	0.00061	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MET—pancreatic cancer	3.62e-05	0.000608	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HSPA1B—pancreatic cancer	3.6e-05	0.000605	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.56e-05	0.000598	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.53e-05	0.000592	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NOTCH1—pancreatic cancer	3.49e-05	0.000585	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GCG—pancreatic cancer	3.49e-05	0.000585	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—TYMS—pancreatic cancer	3.38e-05	0.000568	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SMAD4—pancreatic cancer	3.38e-05	0.000567	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.37e-05	0.000566	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CD44—pancreatic cancer	3.33e-05	0.000558	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GLP1R—pancreatic cancer	3.3e-05	0.000553	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EZH2—pancreatic cancer	3.28e-05	0.000551	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—STK11—pancreatic cancer	3.28e-05	0.00055	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NOTCH1—pancreatic cancer	3.27e-05	0.000548	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.26e-05	0.000547	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—DPYD—pancreatic cancer	3.24e-05	0.000544	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—pancreatic cancer	3.23e-05	0.000543	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.23e-05	0.000542	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TYMP—pancreatic cancer	3.22e-05	0.00054	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH3—pancreatic cancer	3.21e-05	0.000539	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GCG—pancreatic cancer	3.19e-05	0.000535	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP9—pancreatic cancer	3.17e-05	0.000532	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—pancreatic cancer	3.16e-05	0.000531	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PPARG—pancreatic cancer	3.08e-05	0.000518	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC2A2—pancreatic cancer	3.08e-05	0.000517	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.08e-05	0.000516	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.05e-05	0.000511	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HSPA1A—pancreatic cancer	3.04e-05	0.000511	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP2—pancreatic cancer	3.02e-05	0.000507	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—STK11—pancreatic cancer	3e-05	0.000503	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—SRC—pancreatic cancer	2.92e-05	0.00049	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—pancreatic cancer	2.85e-05	0.000478	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TYMS—pancreatic cancer	2.82e-05	0.000473	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—STAT3—pancreatic cancer	2.82e-05	0.000473	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.81e-05	0.000472	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NRAS—pancreatic cancer	2.81e-05	0.000472	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—pancreatic cancer	2.78e-05	0.000467	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—APOE—pancreatic cancer	2.75e-05	0.000462	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.68e-05	0.000449	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PRSS1—pancreatic cancer	2.66e-05	0.000447	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.66e-05	0.000446	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TGFB1—pancreatic cancer	2.61e-05	0.000438	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.61e-05	0.000437	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	2.6e-05	0.000436	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TYMS—pancreatic cancer	2.58e-05	0.000433	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—pancreatic cancer	2.56e-05	0.00043	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—DPYD—pancreatic cancer	2.55e-05	0.000429	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH1—pancreatic cancer	2.49e-05	0.000418	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CG—pancreatic cancer	2.48e-05	0.000417	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PRSS1—pancreatic cancer	2.44e-05	0.00041	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—pancreatic cancer	2.44e-05	0.000409	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	2.42e-05	0.000407	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SMAD4—pancreatic cancer	2.42e-05	0.000406	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—pancreatic cancer	2.42e-05	0.000406	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.4e-05	0.000403	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARG—pancreatic cancer	2.4e-05	0.000402	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CD44—pancreatic cancer	2.38e-05	0.0004	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPARG—pancreatic cancer	2.35e-05	0.000394	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.33e-05	0.000392	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—pancreatic cancer	2.32e-05	0.000389	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.31e-05	0.000388	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.31e-05	0.000388	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ARG2—pancreatic cancer	2.31e-05	0.000388	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—APOE—pancreatic cancer	2.29e-05	0.000385	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GCG—pancreatic cancer	2.29e-05	0.000383	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—pancreatic cancer	2.27e-05	0.000381	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CD—pancreatic cancer	2.18e-05	0.000367	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.17e-05	0.000364	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—STK11—pancreatic cancer	2.15e-05	0.000361	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ARG2—pancreatic cancer	2.12e-05	0.000355	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.11e-05	0.000354	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOE—pancreatic cancer	2.1e-05	0.000352	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—SRC—pancreatic cancer	2.09e-05	0.000351	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CG—pancreatic cancer	2.07e-05	0.000347	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—pancreatic cancer	2.06e-05	0.000345	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—pancreatic cancer	2.04e-05	0.000342	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—pancreatic cancer	2.02e-05	0.000339	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMP—pancreatic cancer	2.02e-05	0.000339	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.02e-05	0.000338	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—pancreatic cancer	2.01e-05	0.000338	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—pancreatic cancer	2e-05	0.000335	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—pancreatic cancer	1.99e-05	0.000335	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.99e-05	0.000333	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CB—pancreatic cancer	1.9e-05	0.000319	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—pancreatic cancer	1.89e-05	0.000318	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—pancreatic cancer	1.89e-05	0.000317	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD44—pancreatic cancer	1.88e-05	0.000315	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—pancreatic cancer	1.87e-05	0.000314	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.85e-05	0.000311	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TYMS—pancreatic cancer	1.85e-05	0.00031	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.84e-05	0.000308	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—pancreatic cancer	1.84e-05	0.000308	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—pancreatic cancer	1.83e-05	0.000307	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.82e-05	0.000306	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CD—pancreatic cancer	1.82e-05	0.000305	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—pancreatic cancer	1.82e-05	0.000305	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GCG—pancreatic cancer	1.8e-05	0.000302	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH1—pancreatic cancer	1.78e-05	0.000299	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—pancreatic cancer	1.76e-05	0.000295	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—pancreatic cancer	1.75e-05	0.000293	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—pancreatic cancer	1.73e-05	0.000291	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.69e-05	0.000284	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.67e-05	0.00028	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CD—pancreatic cancer	1.66e-05	0.000279	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—pancreatic cancer	1.64e-05	0.000276	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.63e-05	0.000273	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.6e-05	0.000269	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.59e-05	0.000267	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CB—pancreatic cancer	1.59e-05	0.000266	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—pancreatic cancer	1.57e-05	0.000264	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.53e-05	0.000256	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.52e-05	0.000255	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.5e-05	0.000252	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—pancreatic cancer	1.5e-05	0.000252	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.49e-05	0.00025	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—pancreatic cancer	1.47e-05	0.000247	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.47e-05	0.000246	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.46e-05	0.000244	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.45e-05	0.000243	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CB—pancreatic cancer	1.45e-05	0.000243	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—pancreatic cancer	1.44e-05	0.000241	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.42e-05	0.000239	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.39e-05	0.000234	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.38e-05	0.000231	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—pancreatic cancer	1.37e-05	0.00023	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—pancreatic cancer	1.36e-05	0.000228	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—pancreatic cancer	1.34e-05	0.000225	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.33e-05	0.000223	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.32e-05	0.000222	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.31e-05	0.00022	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—pancreatic cancer	1.3e-05	0.000218	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—pancreatic cancer	1.25e-05	0.00021	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—pancreatic cancer	1.22e-05	0.000205	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.21e-05	0.000203	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CD—pancreatic cancer	1.19e-05	0.0002	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.18e-05	0.000199	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD44—pancreatic cancer	1.18e-05	0.000197	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—pancreatic cancer	1.16e-05	0.000195	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.15e-05	0.000193	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.14e-05	0.000192	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.14e-05	0.000191	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GCG—pancreatic cancer	1.13e-05	0.000189	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.12e-05	0.000188	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD44—pancreatic cancer	1.08e-05	0.000181	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.07e-05	0.000179	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—STK11—pancreatic cancer	1.06e-05	0.000178	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.06e-05	0.000177	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.05e-05	0.000176	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CB—pancreatic cancer	1.04e-05	0.000174	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCG—pancreatic cancer	1.03e-05	0.000174	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1.03e-05	0.000173	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—pancreatic cancer	1.03e-05	0.000173	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.95e-06	0.000167	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMP—pancreatic cancer	9.93e-06	0.000167	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—STK11—pancreatic cancer	9.72e-06	0.000163	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—pancreatic cancer	9.67e-06	0.000162	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—pancreatic cancer	9.6e-06	0.000161	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—pancreatic cancer	9.48e-06	0.000159	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	9.39e-06	0.000158	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—pancreatic cancer	9.29e-06	0.000156	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.13e-06	0.000153	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMS—pancreatic cancer	9.12e-06	0.000153	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—pancreatic cancer	8.98e-06	0.000151	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—pancreatic cancer	8.84e-06	0.000148	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMS—pancreatic cancer	8.36e-06	0.00014	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	8.18e-06	0.000137	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	8.11e-06	0.000136	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GLP1R—pancreatic cancer	8.01e-06	0.000134	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—pancreatic cancer	7.9e-06	0.000133	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DPYD—pancreatic cancer	7.88e-06	0.000132	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	7.47e-06	0.000125	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—pancreatic cancer	7.42e-06	0.000124	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—pancreatic cancer	7.22e-06	0.000121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—pancreatic cancer	7.07e-06	0.000119	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.02e-06	0.000118	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—pancreatic cancer	6.8e-06	0.000114	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	6.69e-06	0.000112	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—pancreatic cancer	6.66e-06	0.000112	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—pancreatic cancer	6.46e-06	0.000108	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.44e-06	0.000108	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—pancreatic cancer	6.34e-06	0.000106	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	6.14e-06	0.000103	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—pancreatic cancer	5.92e-06	9.94e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	5.89e-06	9.88e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD44—pancreatic cancer	5.79e-06	9.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCG—pancreatic cancer	5.55e-06	9.31e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	5.4e-06	9.06e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—STK11—pancreatic cancer	5.22e-06	8.76e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—pancreatic cancer	5.18e-06	8.69e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	5.13e-06	8.61e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—pancreatic cancer	5.08e-06	8.53e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	4.99e-06	8.37e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	4.7e-06	7.89e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—pancreatic cancer	4.66e-06	7.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.49e-06	7.53e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—pancreatic cancer	4.43e-06	7.44e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—pancreatic cancer	4.08e-06	6.84e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—pancreatic cancer	4.06e-06	6.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—pancreatic cancer	3.65e-06	6.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.29e-06	5.53e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.18e-06	5.34e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	3.13e-06	5.25e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.9e-06	4.86e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.87e-06	4.81e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—pancreatic cancer	2.55e-06	4.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.52e-06	4.24e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.5e-06	4.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.34e-06	3.93e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.18e-06	3.66e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.54e-06	2.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.26e-06	2.11e-05	CbGpPWpGaD
